A PHASE 1, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE-DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN PATIENTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS

Authors
Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2023
This article has no abstract
Epistemonikos ID: 3ce7ce2be6a4b4f0f182314132aef99b4672abb6
First added on: Dec 07, 2023